keyword
https://read.qxmd.com/read/38558746/eosinophilic-pneumonia-induced-by-daptomycin
#21
Juan D Ayala Torres, Brian Noreña, Alma Tatiana Suarez Poveda
Daptomycin-induced eosinophilic pneumonia (DIEP) is a rare but serious complication associated with the use of this broad-spectrum antibiotic. We present the case of a teenager with a history of nasopharyngeal cancer who developed DIEP while receiving daptomycin to treat an infection associated with an implanted chamber catheter. Symptoms included recurrent dyspnea and peripheral eosinophilia, with radiological findings consistent with DIEP. The pathophysiology involves an immune response triggered by daptomycin, resulting in eosinophilic pulmonary inflammation...
February 2024: Curēus
https://read.qxmd.com/read/38554003/safety-and-treatment-outcomes-of-infants-and-children-treated-with-daptomycin-six-year-experience-from-a-pediatric-academic-medical-center
#22
JOURNAL ARTICLE
Bryan J Vonasek, Allison M Samuel, Sheryl L Henderson, Jill R Strayer, Monica C Bogenschutz
Daptomycin is a common treatment for serious infections caused by gram-positive bacteria in adult patients; however, data regarding its safety and efficacy in the pediatric population are limited. This was a retrospective chart review of adverse reactions and treatment outcomes associated with daptomycin use in children <13 years old who received at least 1 dose of daptomycin. At least 1 dose of daptomycin was received by 147 patients. Seventy-two patients received daptomycin for 5 or more days. New-onset loose stools on daptomycin initiation were reported for 14 (9...
March 30, 2024: Clinical Pediatrics
https://read.qxmd.com/read/38552199/revolutionizing-daptomycin-dosing-a-single-7-11-hour-sample-for-pragmatic-application
#23
JOURNAL ARTICLE
Jacopo Angelini, Shuhan Liu, Simone Guiliano, Sarah Flammini, Luca Martini, Carlo Tascini, Massimo Baraldo, Manjunath P Pai
Precision daptomycin dosing faces clinical implementation barriers despite known exposure-safety concerns with the use of twice the regulatory-approved doses. We propose achieving a single 7-11 hour post-dose plasma target concentration of 30 mg/L to 43 mg/L to be a practical starting point to facilitate precision daptomycin dosing.
March 29, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38535549/genomic-insights-into-staphylococcus-aureus-isolates-exhibiting-diminished-daptomycin-susceptibility
#24
JOURNAL ARTICLE
Natalia Gómez-Casanova, Mª Nieves Gutiérrez-Zufiaurre, Ana Mª Blázquez de Castro, Juan Luis Muñoz-Bellido
Daptomycin is one of the last therapeutic resources for multidrug-resistant gram-positive bacteria. Despite its structural similarities with glycopeptides, its mechanisms of action and resistance are different and in some respects are not completely understood. Mutations in several genes have been associated with daptomycin resistance, especially in mprF , walkR , rpoB and rpoC , but their role and importance remain to be elucidated. We have studied mutations in 11 genes, which have been previously associated with daptomycin non-susceptibility, in nine daptomycin-non-susceptible Staphylococcus aureus clinical isolates (daptomycin MIC: >1 mg/L)...
February 26, 2024: Pathogens
https://read.qxmd.com/read/38534689/daptomycin-use-for-persistent-coagulase-negative-staphylococcal-bacteremia-in-a-neonatal-intensive-care-unit
#25
JOURNAL ARTICLE
Eleni Papachatzi, Despoina Gkentzi, Sotiris Tzifas, Theodore Dassios, Gabriel Dimitriou
During the last two decades, the incidence of late-onset sepsis (LOS) has increased due to improved survival of premature neonates. Persistent bacteremia (PB) in LOS is defined as more than two positive blood cultures obtained on different calendar days during the same infectious episode. Although rare, PB should be treated aggressively to prevent adverse outcomes. Daptomycin, a lipopeptide antibiotic, has been used in neonates with persistent coagulase-negative staphylococci (CoNS) bacteremia with promising results, but studies reporting on the efficacy and safety of the agent are scarce...
March 12, 2024: Antibiotics
https://read.qxmd.com/read/38531037/daptomycin-induced-eosinophilic-pneumonia
#26
JOURNAL ARTICLE
Michael R Hassett
Daptomycin-induced eosinophilic pneumonia (DIEP) is a rare complication of daptomycin use. Manifestations most commonly include fever, hypoxia, dyspnea, cough, eosinophilia, and lung changes on radiographs and CT. Patients typically have had recent daptomycin exposure and develop fever, dyspnea, infiltrates on chest radiograph, more than 25% eosinophils on bronchoalveolar lavage, and improvement of symptoms after withdrawal of daptomycin. Treatment includes discontinuation of daptomycin, corticosteroids, and supportive measures such as supplemental oxygen...
April 1, 2024: JAAPA: Official Journal of the American Academy of Physician Assistants
https://read.qxmd.com/read/38530540/the-functional-study-of-response-regulator-arlr-mutants-in-staphylococcus-aureus
#27
JOURNAL ARTICLE
Jinhong Zhou, Moath Refat, Yucheng Guo, Jiaxin Zhang, Min Jiao, Wenbo He, Xiaoyu He, Mai A Rabie, Zhenlin Ouyang, Fang Zheng
Staphylococcus aureus is a major cause of hospital-associated infections worldwide. The organism's ability to form biofilms has led to resistance against current treatment options such as beta-lactams, glycopeptides, and daptomycin. The ArlRS two-component system is a crucial regulatory system necessary for S. aureus autolysis, biofilm formation, capsule synthesis, and virulence. This study aims to investigate the role of the arlR deletion mutant in the detection and activation of S. aureus. We created an arlR deleted mutant and complementary strains and characterized their impact on the strains using partial growth measurement...
March 26, 2024: Applied Biochemistry and Biotechnology
https://read.qxmd.com/read/38527904/an-essential-protease-ftsh-influences-daptomycin-resistance-acquisition-in-enterococcus-faecalis
#28
JOURNAL ARTICLE
Zeus Jaren Nair, Iris Hanxing Gao, Aslam Firras, Kelvin Kian Long Chong, Eric D Hill, Pei Yi Choo, Cristina Colomer-Winter, Qingyan Chen, Caroline Manzano, Kevin Pethe, Kimberly A Kline
Daptomycin is a last-line antibiotic commonly used to treat vancomycin-resistant Enterococci, but resistance evolves rapidly and further restricts already limited treatment options. While genetic determinants associated with clinical daptomycin resistance (DAPR ) have been described, information on factors affecting the speed of DAPR acquisition is limited. The multiple peptide resistance factor (MprF), a phosphatidylglycerol-modifying enzyme involved in cationic antimicrobial resistance, is linked to DAPR in pathogens such as methicillin-resistant Staphylococcus aureus...
March 25, 2024: Molecular Microbiology
https://read.qxmd.com/read/38526291/delayed-response-to-glucocorticoids-in-daptomycin-lung
#29
JOURNAL ARTICLE
Abdelrahman Nanah, Anika Sasidharan Nair, James Stoller
No abstract text is available yet for this article.
March 26, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38525234/antibiotic-resistance-of-gallibacterium-anatis-biovar-haemolytica-isolates-from-chickens
#30
JOURNAL ARTICLE
Olimpia Kursa, Grzegorz Tomczyk, Agata Sieczkowska, Anna Sawicka-Durkalec
INTRODUCTION: Gallibacterium anatis is an opportunistic bacteria inducing a range of clinical signs in poultry. Gallibacterium anatis strains show multidrug resistance to antibacterial substances. The purpose of this study was to examine the susceptibility of G. anatis biovar haemolytica isolates collected from the respiratory, reproduction and gastrointestinal tracts of chickens to different antibiotics from various classes. MATERIAL AND METHODS: Gallibacterium anatis biovar haemolytica was identified in tracheal swab and gastrointestinal and reproductive tract tissue samples from Polish layer and broiler chicken flocks...
March 2024: Journal of Veterinary Research
https://read.qxmd.com/read/38507800/characterization-of-weissella-species-during-a-3-year-observational-study-an-emerging-threat
#31
JOURNAL ARTICLE
Ashima Jamwal, Gerlin Varghese, Deepika Sarawat, Nidhi Tejan, Sangram Singh Patel, Chinmoy Sahu
Weissella species are mistaken for Lactobacillus or Leuconostoc because of their Gram-staining property and resistance to vancomycin. In this study, we aimed to evaluate the demographic pattern, presenting symptoms, risk factors, associated pathologies, and clinical outcomes in patients with Weissella infection. We also analyzed the antibiotic susceptibility pattern of the Weissella species isolated. This retrospective observational study was done from January 2021 to August 2023 in a tertiary care referral center in Uttar Pradesh...
March 19, 2024: American Journal of Tropical Medicine and Hygiene
https://read.qxmd.com/read/38501807/a-machine-learning-approach-to-predict-daptomycin-exposure-from-two-concentrations-based-on-monte-carlo-simulations
#32
JOURNAL ARTICLE
Cyrielle Codde, Florence Rivals, Alexandre Destere, Yeleen Fromage, Marc Labriffe, Pierre Marquet, Clément Benoist, Laure Ponthier, Jean-François Faucher, Jean-Baptiste Woillard
Daptomycin is a concentration-dependent lipopeptide antibiotic for which exposure/effect relationships have been shown. Machine learning (ML) algorithms, developed to predict the individual exposure to drugs, have shown very good performances in comparison to maximum a posteriori Bayesian estimation (MAP-BE). The aim of this work was to predict the area under the blood concentration curve (AUC) of daptomycin from two samples and a few covariates using XGBoost ML algorithm trained on Monte Carlo simulations...
March 19, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38497326/daptomycin-dose-optimization-in-pediatric-staphylococcus-aureus-bacteremia-a-pharmacokinetic-pharmacodynamic-investigation
#33
JOURNAL ARTICLE
Katie B Olney, Joel I Howard, David S Burgess
Daptomycin is an antibiotic with Gram-positive activity, including methicillin-resistant Staphylococcus aureus, for which optimal pediatric dosing is unknown. This study aimed to evaluate daptomycin exposures achieved with package label dosing and to identify dosing regimens necessary to enhance efficacy and minimize toxicity in children with S. aureus bacteremia. Monte Carlo simulations were performed to determine probability of target attainment (PTA) for six pediatric age cohorts. Area under the curve to minimum inhibitory concentration ratio (AUC0-24 :MIC) ≥666 was used to determine the PTA for efficacy (PTAE )...
March 18, 2024: Journal of Clinical Pharmacology
https://read.qxmd.com/read/38494147/whole-genome-sequencing-identifies-mprf-mutations-in-a-genetically-diverse-population-of-daptomycin-non-susceptible-staphylococcus-aureus-in-australia
#34
JOURNAL ARTICLE
Candice Lim, Geoffrey W Coombs, Denise A Daley, Princy Shoby, Shakeel Mowlaboccus
Daptomycin is one of the few last-line antimicrobials available for the treatment of multidrug-resistant Staphylococcus aureus infections. An increasing number of daptomycin non-susceptible S. aureus infections has been reported worldwide, including Australia. Resistance to daptomycin is multifactorial and involves chromosomal mutations in genes encoding proteins involved in cell membrane and cell wall synthesis. In this study, we performed broth microdilution (BMD) to determine the daptomycin minimum inhibitory concentration (MIC) of 66 clinical isolates of S...
March 15, 2024: International Journal of Antimicrobial Agents
https://read.qxmd.com/read/38487127/daptomycin-and-ceftaroline-combination-therapy-in-complicated-endovascular-infections-caused-by-methicillin-resistant-staphylococcus-epidermidis
#35
JOURNAL ARTICLE
Sílvia Policarpo, Raquel Duro, Nuno R Pereira, Lurdes Santos
Background In complicated endovascular infections by methicillin-resistant Staphylococcus aureus (MRSA) or Staphylococcus epidermidis (MRSE), when first-line therapy with vancomycin (VAN) or daptomycin (DAP) fails, combination therapy with ceftaroline (CFT) and DAP has been shown to be a useful approach as salvage therapy for persistent MRSA bacteremia. Objectives This study aimed to describe experience with daptomycin and ceftaroline combination therapy in MRSE-complicated endovascular infections. Methods A single-center retrospective review of consecutive patients with MRSE-complicated endovascular infections treated with ≥72 hours of DAP+CFT at any time during the course of treatment, from January 1, 2016 to December 31, 2020, at Centro Hospitalar Universitário São João (CHUSJ), Porto, Portugal, was conducted...
February 2024: Curēus
https://read.qxmd.com/read/38481761/efficacy-of-rifampicin-combination-therapy-against-mrsa-prosthetic-vascular-graft-infections-in-a-rat-model
#36
JOURNAL ARTICLE
Mikkel Illemann Johansen, Maiken Engelbrecht Petersen, Emma Faddy, Anders Marthinsen Seefeldt, Alexander Alexandrovich Mitkin, Lars Østergaard, Rikke Louise Meyer, Nis Pedersen Jørgensen
Staphylococcus aureus is a major cause of prosthetic vascular graft or endograft infections (VGEIs) and the optimal choice of antibiotics is unclear. We investigated various antibiotic choices as either monotherapy or combination therapy with rifampicin against MRSA in vitro and in vivo . Fosfomycin, daptomycin and vancomycin alone or in combination with rifampicin was used against MRSA USA300 FPR3757. Each antibiotic was tested for synergism or antagonism with rifampicin in vitro, and all antibiotic regimens were tested against actively growing bacteria in media and non-growing bacteria in buffer, both as planktonic cells and in biofilms...
June 2024: Biofilm
https://read.qxmd.com/read/38469769/a-case-report-of-corynebacterium-tuberculostearicum-infection
#37
Xin Huang, Qiuxiang Li, Qing Lin, Chengchuan Jiang, Yu Liao, Bolian Wang, Taijie Li
BACKGROUND: The goal was to report a rare case of lymphadenitis caused by Corynebacterium tuberculostearicum, and the laboratory's coping approach in the isolation and identification of this rare pathogen to improve the understanding of the disease. METHODS: Lymph node biopsy was performed in a patient with suspected tuberculous lymphadenitis, and the biopsy tissue was isolated and cultured. RESULTS: The culture was Gram positive Corynebacterium, which was identified as Corynebacterium tuberculostearicum by microbial mass spectrometry and 16S rRNA gene sequencing...
March 1, 2024: Clinical Laboratory
https://read.qxmd.com/read/38454765/daptomycin-inhibits-multiple-myeloma-progression-through-downregulating-the-expression-of-rps19
#38
JOURNAL ARTICLE
Yijun Zhuang, Yin Zhang, Caiyun Chen, Jincheng Chen, Qiuxia Xu, Peihong Wang
OBJECTIVES: This study aimed to explore new therapeutic drugs for multiple myeloma (MM). MM is a common plasma cell malignant proliferative disease, accounting for 15% of hematological malignancies. The role of daptomycin (DAP), a potential anti-tumor drug, remains unclear in MM. In the present research, we investigated the anticancer effect of DAP in MM cell line RPMI 8226. METHODS: RPMI 8226 cells were treated with DAP (20 μM, 40 μM, and 80 μM) with 20 nM bortezomib (BZ) as a positive control...
March 6, 2024: Combinatorial Chemistry & High Throughput Screening
https://read.qxmd.com/read/38449986/rapid-aggravation-of-rhabdomyolysis-caused-by-daptomycin-after-aortic-arch-replacement-a-case-report
#39
Kenichi Takechi, Mayuko Fujimoto, Tomoko Abe, Ichiro Shimizu
Although rare, rhabdomyolysis is a serious complication of cardiothoracic surgery. Daptomycin is a polypeptide antimicrobial agent used to treat methicillin-resistant Staphylococcus aureus (MRSA) infections of the soft tissues. Daptomycin is associated with elevations in serum creatine kinase (CK). A 50-year-old man with acute Stanford A-type aortic dissection was performed Bentall procedure and total arch replacement with frozen elephant trunk. The CK level was 6,573 U/L on the first postoperative day (POD), suggesting rhabdomyolysis associated with lower limb ischemia...
February 2024: Curēus
https://read.qxmd.com/read/38447811/telodendrimer-functionalized-hydrogel-platform-for-sustained-antibiotics-release-in-infection-control
#40
JOURNAL ARTICLE
Xiguang Yang, Dandan Guo, Xiaotian Ji, Changying Shi, Jennifer M Messina, Liye Suo, Juntao Luo
Wound infection commonly causes delayed healing, especially in the setting of chronic wounds. Local release of antibiotics is considered a viable approach to treat chronic wounds. We have developed a versatile telodendrimer (TD) platform for efficient loading of charged antibiotic molecules via a combination of multivalent and synergistic charge and hydrophobic interactions. The conjugation of TD in biocompatible hydrogel allows for topical application to provide sustained antibiotic release. Notably, a drug loading capacity as high as 20% of the drug-to-resin dry weight ratio can be achieved...
March 4, 2024: Acta Biomaterialia
keyword
keyword
1812
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.